|
"hung cc"的相關文件
顯示項目 16-25 / 233 (共24頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-07-21 |
Zoledronate as a preventative measure for bone loss following denosumab discontinuation: Results from a multi-institutional randomized controlled trial
|
Fu, SH;Lee, CC;Hung, CC;Li, CY;Wang, CY |
| 國家衛生研究院 |
2023-06-21 |
Diagnostic accuracy of algorithms to define incident and second hip fractures: A Taiwan validation study
|
Fu, SH;Yu, PY;Li, CY;Hung, CC;Lee, CC;Chen, HY;Tai, TW;Hwang, JS;Yang, RS;Chiang, H;Lin, SY;Wu, CH;Liao, LC;Chuang, CJ;Wu, CY;Chang, CY;Lee, MT;Chen, CH;Wang, CY |
| 國家衛生研究院 |
2023-03-08 |
Factors associated with viral rebound among COVID-19 patients receiving oral antivirals
|
Chen, PY;Wang, JT;Chang, SY;Hung, CC;Fang, CT;Cheng, A;Liu, WD;Huang, YS;Lin, KY;Sun, HY;Pan, SC;Cheng, YC;Wang, HY;Sheng, WH;Chen, YC;Ho, YL;Wu, MS;Chang, SC |
| 國家衛生研究院 |
2022-12 |
Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV
|
Liu, WD;Pang, MW;Wang, JT;Sun, HY;Huang, YS;Lin, KY;Wu, UI;Li, GC;Liu, WC;Su, YC;He, PC;Lin, CY;Yeh, CY;Cheng, YC;Yao, Y;Chen, YT;Wu, PY;Chen, LY;Luo, YZ;Chang, HY;Sheng, WH;Hsieh, SM;Chang, SY;Hung, CC;Chang, SC |
| 國家衛生研究院 |
2022-11-29 |
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19
|
Liu, WD;Wang, JT;Chao, TL;Ieong, SM;Tsai, YM;Kuo, PH;Tsai, MJ;Chen, YJ;Li, GC;Ho, SY;Chen, HH;Huang, YS;Hung, CC;Chen, YC;Chang, SY;Chang, SC |
| 國家衛生研究院 |
2022-09-13 |
UMOD mutations in chronic kidney disease in Taiwan
|
Chen, HD;Yu, CC;Yang, IH;Hung, CC;Kuo, MC;Tarng, DC;Chang, JM;Hwang, DY |
| 國家衛生研究院 |
2022-07-01 |
PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan
|
Yu, CC;Lee, AF;Kohl, S;Lin, MY;Cheng, SM;Hung, CC;Chang, JM;Chiu, YW;Hwang, SJ;Otto, EA;Hildebrandt, F;Consortium, Taiwan PKD;Hwang, DY |
| 國家衛生研究院 |
2022-05-02 |
Three-stage pooled plasma hepatitis C virus RNA testing for the identification of acute HCV infections in at-risk populations
|
Sun, HY;Chiang, C;Huang, SH;Guo, WJ;Chuang, YC;Huang, YC;Yang, CJ;Su, LH;Chen, YT;Chen, YW;Hsu, FC;Ho, SY;Liu, WC;Su, YC;Chang, SY;Hsiao, CF;Hung, CC;Yu, ML |
| 國家衛生研究院 |
2021-06-01 |
Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV
|
Huang, SH;Huang, WC;Lin, SW;Chuang, YC;Sun, HY;Chang, SY;Kuo, PH;Wu, PY;Liu, WC;Chiang, C;Hung, CC;Chang, SC |
| 中山醫學大學 |
2021 |
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients
|
Huang, YS; Cheng, CY; Liou, BH; Lu, PL; Cheng, SH; Lee, YT; Liu, CE; Sun, HY; Yang, CJ; Tang, HJ; Lin, SP; Ho, MW; Huang, SH; Tsai, HC; Lee, CH; Hung, CC |
顯示項目 16-25 / 233 (共24頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
